Similar articles for PMID: 27432381

Year	Number of Results
1989	1
1994	1
1999	1
2000	1
2002	1
2003	2
2004	3
2005	3
2006	1
2007	8
2008	3
2009	7
2010	7
2011	6
2012	5
2013	4
2014	11
2015	14
2016	20
2017	11
2018	8
2019	16
2020	17
2021	11
2022	9
2023	3
2024	0

1

Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.

Steinhoff M, Vocanson M, Voegel JJ, Hacini-Rachinel F, Schäfer G. Steinhoff M, et al. Adv Ther. 2016 Sep;33(9):1481-501. doi: 10.1007/s12325-016-0380-z. Epub 2016 Jul 18. Adv Ther. 2016. PMID: 27432381 Free PMC article. Review.

2

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.

Schaller M, Kemény L, Havlickova B, Jackson JM, Ambroziak M, Lynde C, Gooderham M, Remenyik E, Del Rosso J, Weglowska J, Chavda R, Kerrouche N, Dirschka T, Johnson S. Schaller M, et al. J Am Acad Dermatol. 2020 Feb;82(2):336-343. doi: 10.1016/j.jaad.2019.05.063. Epub 2019 May 29. J Am Acad Dermatol. 2020. PMID: 31150711 Free article. Clinical Trial.

3

Optimal management of papulopustular rosacea: rationale for combination therapy.

Bhatia ND, Del Rosso JQ. Bhatia ND, et al. J Drugs Dermatol. 2012 Jul;11(7):838-44. J Drugs Dermatol. 2012. PMID: 22777226 Review.

4

Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.

Schaller M, Gonser L, Belge K, Braunsdorf C, Nordin R, Scheu A, Borelli C. Schaller M, et al. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1907-1911. doi: 10.1111/jdv.14437. Epub 2017 Aug 29. J Eur Acad Dermatol Venereol. 2017. PMID: 28653460

5

Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.

Taieb A, Stein Gold L, Feldman SR, Dansk V, Bertranou E. Taieb A, et al. J Manag Care Spec Pharm. 2016 Jun;22(6):654-65. doi: 10.18553/jmcp.2016.15210. Epub 2016 Apr 28. J Manag Care Spec Pharm. 2016. PMID: 27231793 Free PMC article.

6

A Sequential Approach to the Treatment of Severe Papulopustular Rosacea Not Responding to Traditional Treatment.

Dirschka T, Schmitz L, Bartha Á. Dirschka T, et al. J Drugs Dermatol. 2016 Jun 1;15(6):769-71. J Drugs Dermatol. 2016. PMID: 27272088

7

Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.

Del Rosso JQ. Del Rosso JQ. Cutis. 2010 Nov;86(5 Suppl):16-25. Cutis. 2010. PMID: 21229827 Clinical Trial.

8

Ivermectin 1% cream for rosacea.

Gupta G, Daigle D, Gupta AK, Gold LS. Gupta G, et al. Skin Therapy Lett. 2015 Jul-Aug;20(4):9-11. Skin Therapy Lett. 2015. PMID: 26382711 Free article. Review.

9

Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.

Fowler JF Jr. Fowler JF Jr. J Drugs Dermatol. 2007 Jun;6(6):641-5. J Drugs Dermatol. 2007. PMID: 17668530 Clinical Trial.

10

Ivermectin 1% (CD5024) for the treatment of rosacea.

Sahni DR, Feldman SR, Taylor SL. Sahni DR, et al. Expert Opin Pharmacother. 2018 Apr;19(5):511-516. doi: 10.1080/14656566.2018.1447562. Epub 2018 Mar 16. Expert Opin Pharmacother. 2018. PMID: 29544355 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

162 results

Results by year